Novartis Ag (NVS) Non Operating Interest Expenses (2009 - 2026)
Novartis Ag's Non Operating Interest Expenses came in at $462 million for Q2 2026, up 59.9% from $289 million a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Non Operating Interest Expenses of -$466 million; for FY2025, it was $1.14 billion, up 13.7% from FY2024.
- Non Operating Interest Expenses has increased in each of the last four years, with a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
- Going back by year, Non Operating Interest Expenses was $1.01 billion in FY2024 (+17.7%), $855 million in FY2023 (+6.9%), $800 million in FY2022 (+1.7%) and $787 million in FY2021 (-9.4%).
- The Q2 2026 figure represents the highest quarterly Non Operating Interest Expenses in data going back to Q1 2009.
- Business Quant data shows NVS's Non Operating Interest Expenses at -$343 million (Q1 2026), -$304 million (Q4 2025) and -$281 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | - |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 137.20 Bn | 109.19 Bn | 2.91 Bn | 36.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 462.00 Mn |
| Mar 31, 2026 | -343.00 Mn |
| Dec 31, 2025 | -304.00 Mn |
| Sep 30, 2025 | -281.00 Mn |
| Jun 30, 2025 | 289.00 Mn |
| Mar 31, 2025 | -270.00 Mn |
| Dec 31, 2024 | -275.00 Mn |
| Sep 30, 2024 | -264.00 Mn |
| Jun 30, 2024 | 246.00 Mn |
| Mar 31, 2024 | -221.00 Mn |
| Dec 31, 2023 | -217.00 Mn |
| Sep 30, 2023 | -222.00 Mn |
| Jun 30, 2023 | 216.00 Mn |
| Mar 31, 2023 | -200.00 Mn |
| Dec 31, 2022 | -207.00 Mn |
| Sep 30, 2022 | -206.00 Mn |
| Jun 30, 2022 | 202.00 Mn |
| Mar 31, 2022 | -201.00 Mn |
| Dec 31, 2021 | -206.00 Mn |
| Sep 30, 2021 | -202.00 Mn |
API Access
Novartis Ag Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();